WC
OMIC

Weil Company’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Weil Company’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,273
Closed -$35.1K – 164
2024
Q1 		$35.1K Sell
2,273
-2,334
-51% -$35.6K 0.01% 152
2023
Q4 		$63.6K Buy
4,607
+667
+17% +$7.89K 0.03% 135
2023
Q3 		$45K Buy
3,940
+1,667
+73% +$31K 0.02% 132
2023
Q2 		$56.6K Buy
2,273
+500
+28% +$14.6K 0.03% 145
2023
Q1 		$64.4K Hold
1,773
– – 0.03% 141
2022
Q4 		$107K Buy
+1,773
New +$119K 0.05% 137

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Weil Company's OMIC Position: Q2 2024 in Review

Weil Company sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 2,273 shares — an estimated $35.1K sold.

Weil Company first reported a position in OMIC in Q4 2022 and held it in 6 quarters. The position peaked at $107K in Q4 2022. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • Weil Company reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Weil Company sold 2,273 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $35.1K.
  • Weil Company first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Weil Company's Singular Genomics Systems, Inc. Common Stock position peaked at $107K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on Weil Company's 13F filing for Q2 2024, filed 5 Aug 2024.